INC Research Holdings, Inc. (NASDAQ:INCR) will be posting its quarterly earnings results before the market opens on Thursday, November 9th. Analysts expect INC Research Holdings to post earnings of $0.63 per share for the quarter.

A number of equities research analysts have recently issued reports on the stock. Goldman Sachs Group, Inc. (The) reissued a “buy” rating and issued a $65.00 price target on shares of INC Research Holdings in a research note on Monday, August 7th. Zacks Investment Research downgraded shares of INC Research Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Credit Suisse Group assumed coverage on shares of INC Research Holdings in a research note on Wednesday, October 11th. They issued an “outperform” rating and a $68.00 price target on the stock. Mizuho assumed coverage on shares of INC Research Holdings in a research note on Thursday, September 21st. They issued a “neutral” rating and a $57.00 price target on the stock. Finally, Jefferies Group LLC raised shares of INC Research Holdings from a “hold” rating to a “buy” rating and boosted their price target for the company from $62.50 to $69.00 in a research note on Monday, October 9th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. INC Research Holdings currently has a consensus rating of “Buy” and an average target price of $64.22.

TRADEMARK VIOLATION WARNING: This article was first reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/11/02/inc-research-holdings-inc-incr-to-release-earnings-on-thursday.html.

In related news, CAO Christopher L. Gaenzle sold 42,601 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $58.67, for a total transaction of $2,499,400.67. Following the sale, the chief accounting officer now directly owns 69,557 shares of the company’s stock, valued at approximately $4,080,909.19. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Alistair Macdonald sold 8,828 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $55.65, for a total transaction of $491,278.20. Following the sale, the chief executive officer now directly owns 110,629 shares in the company, valued at $6,156,503.85. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 198,321 shares of company stock worth $11,550,792. 0.24% of the stock is owned by insiders.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Earnings History for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.